<- Go home

Added to YB: 2023-02-11

Pitch date: 2023-02-11

ORMP [bullish]

Oramed Pharmaceuticals Inc.

+40.18%

current return

Author Info

Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.

Company Info

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.

Market Cap

$95.6M

Pitch Price

$2.19

Price Target

N/A

Dividend

N/A

EV/EBITDA

3.11

P/E

2.34

EV/Sales

-19.57

Sector

Pharmaceuticals

Category

N/A

Show full summary:
Oramed Pharmaceuticals: Trading Well Below Cash, Strategic Alternatives

A summary for this pitch has not been created yet.

Read full article (1 min)